This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård +19 more
wiley +1 more source
Ultrasmall episymbiont Nanosynbacter lyticus employs multiple ATP-generating metabolic pathways during horizontal transmission. [PDF]
Nahar N +9 more
europepmc +1 more source
EP300 confers protection against acute pancreatitis via acetylating HSF1 and promoting PRKN-mediated mitophagy in pancreatic acinar cells. [PDF]
Zhu L +8 more
europepmc +1 more source
Cluster of Severe Arginase 1 Deficiency in the Comoros: Clinical, Neuroimaging, and Molecular Features in 17 Patients From Mayotte Compared With 10 From Paris. [PDF]
De Bruyne A +16 more
europepmc +1 more source
Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats. [PDF]
Madzarac G +22 more
europepmc +1 more source
Solute carrier family (SLC) amino acid transporters are upregulated in cutaneous squamous cell carcinoma. [PDF]
Petrilli A +8 more
europepmc +1 more source
Correction: Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity.
Carroll B +12 more
europepmc +1 more source

